{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:13:10Z","timestamp":1793052790524,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000102","name":"HRSA","doi-asserted-by":"publisher","award":["H46MC24090"],"award-info":[{"award-number":["H46MC24090"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002248","name":"MSUD Family Support Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ymgme.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T18:30:28Z","timestamp":1400351428000},"page":"210-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"title":["Nutrition management guideline for maple syrup urine disease: An evidence- and consensus-based approach"],"prefix":"10.1016","volume":"112","author":[{"given":"Dianne M.","family":"Frazier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Allgeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Homer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Marriage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Splett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrya","family":"Stembridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani H.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.05.006_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2753.2011.01807.x","article-title":"Bridging evidence and consensus methodology for inherited metabolic disorders: creating nutrition guidelines","volume":"19","author":"Singh","year":"2013","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0010","doi-asserted-by":"crossref","first-page":"17792","DOI":"10.1074\/jbc.M313879200","article-title":"Structural and biochemical basis for novel mutations in homozygous Israeli maple syrup urine disease patients: a proposed mechanism for the thiamin-responsive phenotype","volume":"279","author":"Chuang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0015","author":"OMIM \u2014 Online Mendelian Inheritance in Man, Maple Syrup Urine Disease: MSUD"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0020","article-title":"Maple Syrup Urine Disease (Branched-chain Ketoaciduria)","author":"Chuang","year":"2008"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1096-7192(03)00144-6","article-title":"Relationship of causative genetic mutations in maple syrup urine disease with their clinical expression","volume":"80","author":"Nellis","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0030","series-title":"GeneReviews, University of Washington, Seattle","first-page":"1993","article-title":"Maple syrup urine disease","author":"Strauss","year":"2006"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1023\/B:BOLI.0000045839.08631.9d","article-title":"Hyperhydroxyprolinaemia detected in newborn screening with tandem mass spectrometry","volume":"27","author":"Baykal","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ymgme.2009.11.010","article-title":"Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms","volume":"100","author":"Puckett","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2004.11.010","article-title":"Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification","volume":"84","author":"Heldt","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0055","series-title":"Academy of Nutrition and Dietetics. Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process","year":"2012"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0060","author":"Genetic Metabolic Dietetians International"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0065","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM199101173240307","article-title":"Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease","volume":"324","author":"Berry","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0075","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ndt\/14.4.910","article-title":"Dialysis in neonates with inborn errors of metabolism","volume":"14","author":"Schaefer","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0080","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s00134-001-1124-2","article-title":"Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease","volume":"27","author":"Jouvet","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0085","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1542\/peds.109.6.999","article-title":"Diagnosis and treatment of maple syrup disease: a study of 36 patients","volume":"109","author":"Morton","year":"2002","journal-title":"Pediatrics"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.05.006_bb0090","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1007\/s10545-008-0859-0","article-title":"Maple syrup urine disease (MSUD) \u2014 clinical profile of 47 Filipino patients","volume":"31","author":"Lee","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0095","first-page":"31","article-title":"Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease","volume":"6","author":"McMahon","year":"1990","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0105","series-title":"Nutrition Management of Patients with Inherited Metabolic Disorders","first-page":"175","article-title":"Nutrition management of patients with inherited disorders of branched-chain amino acid metabolism","author":"Marriage","year":"2010"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1542\/peds.92.2.280","article-title":"Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease","volume":"92","author":"Parini","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00467-001-0801-2","article-title":"Utility of hemodialysis in maple syrup urine disease","volume":"17","author":"Puliyanda","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/adc.67.11.1387","article-title":"Intercurrent illness in inborn errors of intermediary metabolism","volume":"67","author":"Dixon","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10545-005-0457-3","article-title":"Breastfeeding experience in inborn errors of metabolism other than phenylketonuria","volume":"28","author":"Huner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10545-006-0332-x","article-title":"Breast feeding in IMD","volume":"29","author":"MacDonald","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0135","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0022-3476(05)82198-5","article-title":"Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism","volume":"118","author":"Thompson","year":"1991","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11940-003-0039-3","article-title":"Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease","volume":"5","author":"Strauss","year":"2003","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","article-title":"Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease","volume":"82","author":"Sch\u00f6nberger","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01800354","article-title":"Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination","volume":"15","author":"Treacy","year":"1992","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","article-title":"Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD","volume":"59","author":"Hoffmann","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(05)81037-6","article-title":"Intellectual outcome in children with maple syrup urine disease","volume":"119","author":"Kaplan","year":"1991","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02072492","article-title":"Intellectual performance of children with maple syrup urine disease","volume":"152","author":"Hilliges","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0190-9622(93)70036-S","article-title":"Dermatitis in treated maple syrup urine disease","volume":"28","author":"Koch","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0420.1996.tb00386.x","article-title":"Corneal deepithelialization caused by acute deficiency of isoleucine during treatment of a patient with maple syrup urine disease","author":"Tornqvist","year":"1996","journal-title":"Acta Ophthalmol. Scand. Suppl."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-006-0223-1","article-title":"Neuropsychometric outcome predictors for adults with maple syrup urine disease","volume":"29","author":"le Roux","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0185","author":"L.P.I. Micronutrient Information Center","year":"2007"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0190","doi-asserted-by":"crossref","first-page":"e934","DOI":"10.1542\/peds.2006-1783","article-title":"Newborn screening fact sheets","volume":"118","author":"Kaye","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(71)91041-5","article-title":"Thiamine-responsive maple-syrup-urine disease","volume":"1","author":"Scriver","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1012767127434","article-title":"Thiamin-responsive maple syrup urine disease: seizures after 7years of satisfactory metabolic control","volume":"24","author":"Delis","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1203\/00006450-197803000-00016","article-title":"In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate","volume":"12","author":"Danner","year":"1978","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1651-2227.1978.tb16336.x","article-title":"Effects of thiamine in a patient with a variant form of branched-chian ketoaciduria","volume":"67","author":"Duran","year":"1978","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/bmmb.1993.1037","article-title":"Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase","volume":"49","author":"Ellerine","year":"1993","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1203\/00006450-198510000-00012","article-title":"Thiamine response in maple syrup urine disease","volume":"19","author":"Fernhoff","year":"1985","journal-title":"Pediatr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.05.006_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF01800663","article-title":"Thiamine-responsive inborn errors of metabolism","volume":"8","author":"Duran","year":"1985","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0230","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/S0021-9258(18)94087-1","article-title":"Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex","volume":"264","author":"Fisher","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1172\/JCI119586","article-title":"E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype","volume":"100","author":"Chuang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0240","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-3476(85)80413-3","article-title":"So-called thiamin-responsive maple syrup urine disease: 15-year follow-up of the original patient","volume":"107","author":"Scriver","year":"1985","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1005396823030","article-title":"Pregnancy in a woman with maple syrup urine disease","volume":"21","author":"Gr\u00fcnewald","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ajmg.1320440523","article-title":"Case reports of successful pregnancy in women with maple syrup urine disease and propionic acidemia","volume":"44","author":"Van Calcar","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0255","article-title":"Diagnostics and treatment of MSUD in Germany","volume":"22","author":"Wendel","year":"2004","journal-title":"MSUD Fam. Newsl."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10545-005-0252-1","article-title":"Pregnancy issues in inherited metabolic disorders","volume":"29","author":"Lee","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0265","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-3046.2010.01411.x","article-title":"Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series","volume":"15","author":"Shellmer","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0270","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-6143.2005.01209.x","article-title":"Elective liver transplantation for the treatment of classical maple syrup urine disease","volume":"6","author":"Strauss","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.05.006_bb0275","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/PL00014324","article-title":"Liver transplantation in maple syrup urine disease","volume":"158","author":"Wendel","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0280","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.20744","article-title":"Domino liver transplantation in maple syrup urine disease","volume":"12","author":"Khanna","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0285","article-title":"Liver transplantation for maple syrup disease: our perspective as pediatricians","volume":"22","author":"Morton","year":"2005","journal-title":"MSUD Fam. Support Newsl."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0290","series-title":"Medical Management of MSUD. MSUD Family Support Newsletter 25","author":"Berry","year":"2008"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2009.06.067","article-title":"An ethical and policy analysis of elective transplantation for metabolic conditions diagnosed by newborn screening","volume":"156","author":"Ross","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0300","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1056\/NEJM200512013532220","article-title":"Domino hepatic transplantation in maple syrup urine disease","volume":"353","author":"Barshop","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0305","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/A:1026708618507","article-title":"Branched-chain l-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation","volume":"23","author":"Bodner-Leidecker","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ymgme.2007.11.002","article-title":"A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency","volume":"93","author":"Arnold","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/siny.2001.0087","article-title":"Branched-chain organic acidurias","volume":"7","author":"Ogier de Baulny","year":"2002","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-011-9380-y","article-title":"Clinical practice and the development of evidence","volume":"35","author":"Wilcken","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0325","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0330","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbr.2012.03.004","article-title":"Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease","volume":"231","author":"Scaini","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0335","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2009.06.007","article-title":"Profiling of oxidative stress in patients with inborn errors of metabolism","volume":"98","author":"Mc Guire","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0340","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbadis.2009.08.006","article-title":"Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)","volume":"1792","author":"Skvorak","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/hmg\/ddq507","article-title":"Phenylbutyrate therapy for maple syrup urine disease","volume":"20","author":"Brunetti-Pierri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11011-011-9238-x","article-title":"In vivo neuroprotective effect of l-carnitine against oxidative stress in maple syrup urine disease","volume":"26","author":"Mescka","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2014.05.006_bb0355","series-title":"Nutrition Management of Patients with Inherited Metabolic Disorders","first-page":"126","article-title":"Nutrition management of patients with inherited disorders of aromatic amino acid metabolism","author":"Acosta","year":"2010"},{"key":"10.1016\/j.ymgme.2014.05.006_bb0360","author":"Independence Blue Cross, Medical Foods, Low-Protein Modified Food Products, Enteral Nutrition, and Nutritional Formulas Policy Bulletin"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T15:08:20Z","timestamp":1716736100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1096719214001607"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition management guideline for maple syrup urine disease: An evidence- and consensus-based approach","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}